Randomized Controlled Trial of Health Care to Elderly Patients.

This study has been completed.
Sponsor:
Collaborator:
The Royal Norwegian Ministry of Health
Information provided by (Responsible Party):
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT00235404
First received: October 7, 2005
Last updated: March 27, 2012
Last verified: March 2012

October 7, 2005
March 27, 2012
September 2003
Not Provided
  • Number of readmissions [ Time Frame: Within 60 days ] [ Designated as safety issue: No ]
  • Number of deaths [ Time Frame: Within 12 months ] [ Designated as safety issue: No ]
  • Need of home nursing services [ Time Frame: within 12 months ] [ Designated as safety issue: No ]
  • Number of days initially hospitalized
  • Number of deaths within six months and one year
  • Need of home nursing services after six and twelve months
  • Number of readmisisons within 60 days
Complete list of historical versions of study NCT00235404 on ClinicalTrials.gov Archive Site
Costs [ Time Frame: Within 12 months ] [ Designated as safety issue: No ]
Cost
Not Provided
Not Provided
 
Randomized Controlled Trial of Health Care to Elderly Patients.
Specialized Treatment and Care Intervention at a Primary Level in a Nursing Home Compared to Conventional Treatment at a Hospital: a Randomized Controlled Trial.

To study the efficacy of multicomponent treatment and care for patients with acute illness or deterioration of a chronic disease at a nursing home in primary health care compared to traditional treatment at hospital.

Managers at St. Olavs University Hospital and the City of Trondheim local authority decided in 2001 to establish a reinforced department at a nursing home with a multicomponent approach to patient treatment.

In the study treatment at a nursing home will be compared with conventional treatment in ordinary hospital beds in medical, surgical and orthopedic departments at a hospital. Participating doctors at the hospital together with general practitioners shall develope inclusion criteria through Delphi technique. Eligible participants will be hospitalized from their ordinary home and expected to return to home after treatment. When an eligible patient is identified and accepted for inclusion, randomization will be performed by the Clinical Research Department at the Faculty of Medicine.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
  • Congestive Heart Failure
  • Angina Pectoris
  • Asthma
  • Pneumonia
  • Fractures
  • Other: Multicomponent treatment
    Specialized care in preparing recharge to home
  • Other: usual care
    Usual recharge directly from hospital to home
  • Experimental: Intermediate community hospital
    Intervention: Other: Multicomponent treatment
  • Active Comparator: Usual care
    Intervention: Other: usual care

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
142
May 2005
Not Provided

Inclusion Criteria:

  • Participating doctors at the hospital together with general practitioners shall develope inclusion criteria through Delphi technique.

Exclusion Criteria:

  • Participating doctors at the hospital together with general practitioners shall develope exclusion criteria through Delphi technique.
Both
60 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Norway
 
NCT00235404
REK 037-03
No
Norwegian University of Science and Technology
Norwegian University of Science and Technology
The Royal Norwegian Ministry of Health
Study Chair: Roar Johnsen The Norwegian University of Science and Technology (NTNU)
Norwegian University of Science and Technology
March 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP